世界の凍結乾燥ヒト狂犬病ワクチン(Vero細胞)市場2023年:企業・地域・タイプ・用途別分析

◆英語タイトル:Global Freeze-dried Human Rabies Vaccine (Vero Cells) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書(GIR23SM7859)◆商品コード:GIR23SM7859
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2023年9月
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の凍結乾燥ヒト狂犬病ワクチン(Vero細胞)市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

凍結乾燥ヒト狂犬病ワクチン(Vero細胞)市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・単箱、中箱

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Sanofi Pasteur、Serum Institute of India Pvt.、Bavarian Nordic、Bharat Biotech、AIM Vaccine、Liaoning Yisheng Biopharma、Changchun Zhuoyi Biological、Changchun Lnstitute of Biological Products、Liaoning Chengda Biotechnology、Wuhan Institute of Biological Products、ShanDong Yidu Biotechnology、Hualan Biological Bacterin、Guangzhou Promise Biologics

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、凍結乾燥ヒト狂犬病ワクチン(Vero細胞)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な凍結乾燥ヒト狂犬病ワクチン(Vero細胞)メーカーの企業概要、2019年~2022年までの凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な凍結乾燥ヒト狂犬病ワクチン(Vero細胞)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの凍結乾燥ヒト狂犬病ワクチン(Vero細胞)のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での凍結乾燥ヒト狂犬病ワクチン(Vero細胞)市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の産業チェーンを掲載しています。
・第14、15章では、凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の概要
– タイプ別分析(2018年vs2022年vs2029年):単箱、中箱
– 用途別分析(2018年vs2022年vs2029年):病院、診療所
– 世界の凍結乾燥ヒト狂犬病ワクチン(Vero細胞)市場規模・予測
– 世界の凍結乾燥ヒト狂犬病ワクチン(Vero細胞)生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Sanofi Pasteur、Serum Institute of India Pvt.、Bavarian Nordic、Bharat Biotech、AIM Vaccine、Liaoning Yisheng Biopharma、Changchun Zhuoyi Biological、Changchun Lnstitute of Biological Products、Liaoning Chengda Biotechnology、Wuhan Institute of Biological Products、ShanDong Yidu Biotechnology、Hualan Biological Bacterin、Guangzhou Promise Biologics
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:単箱、中箱
・用途別分析2018年-2029年:病院、診療所
・凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・凍結乾燥ヒト狂犬病ワクチン(Vero細胞)のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・凍結乾燥ヒト狂犬病ワクチン(Vero細胞)のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・凍結乾燥ヒト狂犬病ワクチン(Vero細胞)の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Freeze-dried Human Rabies Vaccine (Vero Cells)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Single Box
1.3.3 Middle Box
1.4 Market Analysis by Application
1.4.1 Overview: Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size & Forecast
1.5.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (2018-2029)
1.5.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.1.4 Sanofi Pasteur Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 Serum Institute of India Pvt.
2.2.1 Serum Institute of India Pvt. Details
2.2.2 Serum Institute of India Pvt. Major Business
2.2.3 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.2.4 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Serum Institute of India Pvt. Recent Developments/Updates
2.3 Bavarian Nordic
2.3.1 Bavarian Nordic Details
2.3.2 Bavarian Nordic Major Business
2.3.3 Bavarian Nordic Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.3.4 Bavarian Nordic Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bavarian Nordic Recent Developments/Updates
2.4 Bharat Biotech
2.4.1 Bharat Biotech Details
2.4.2 Bharat Biotech Major Business
2.4.3 Bharat Biotech Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.4.4 Bharat Biotech Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bharat Biotech Recent Developments/Updates
2.5 AIM Vaccine
2.5.1 AIM Vaccine Details
2.5.2 AIM Vaccine Major Business
2.5.3 AIM Vaccine Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.5.4 AIM Vaccine Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AIM Vaccine Recent Developments/Updates
2.6 Liaoning Yisheng Biopharma
2.6.1 Liaoning Yisheng Biopharma Details
2.6.2 Liaoning Yisheng Biopharma Major Business
2.6.3 Liaoning Yisheng Biopharma Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.6.4 Liaoning Yisheng Biopharma Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Liaoning Yisheng Biopharma Recent Developments/Updates
2.7 Changchun Zhuoyi Biological
2.7.1 Changchun Zhuoyi Biological Details
2.7.2 Changchun Zhuoyi Biological Major Business
2.7.3 Changchun Zhuoyi Biological Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.7.4 Changchun Zhuoyi Biological Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Zhuoyi Biological Recent Developments/Updates
2.8 Changchun Lnstitute of Biological Products
2.8.1 Changchun Lnstitute of Biological Products Details
2.8.2 Changchun Lnstitute of Biological Products Major Business
2.8.3 Changchun Lnstitute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.8.4 Changchun Lnstitute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Changchun Lnstitute of Biological Products Recent Developments/Updates
2.9 Liaoning Chengda Biotechnology
2.9.1 Liaoning Chengda Biotechnology Details
2.9.2 Liaoning Chengda Biotechnology Major Business
2.9.3 Liaoning Chengda Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.9.4 Liaoning Chengda Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Liaoning Chengda Biotechnology Recent Developments/Updates
2.10 Wuhan Institute of Biological Products
2.10.1 Wuhan Institute of Biological Products Details
2.10.2 Wuhan Institute of Biological Products Major Business
2.10.3 Wuhan Institute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.10.4 Wuhan Institute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.11 ShanDong Yidu Biotechnology
2.11.1 ShanDong Yidu Biotechnology Details
2.11.2 ShanDong Yidu Biotechnology Major Business
2.11.3 ShanDong Yidu Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.11.4 ShanDong Yidu Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ShanDong Yidu Biotechnology Recent Developments/Updates
2.12 Hualan Biological Bacterin
2.12.1 Hualan Biological Bacterin Details
2.12.2 Hualan Biological Bacterin Major Business
2.12.3 Hualan Biological Bacterin Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.12.4 Hualan Biological Bacterin Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hualan Biological Bacterin Recent Developments/Updates
2.13 Guangzhou Promise Biologics
2.13.1 Guangzhou Promise Biologics Details
2.13.2 Guangzhou Promise Biologics Major Business
2.13.3 Guangzhou Promise Biologics Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.13.4 Guangzhou Promise Biologics Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Guangzhou Promise Biologics Recent Developments/Updates
3 Competitive Environment: Freeze-dried Human Rabies Vaccine (Vero Cells) by Manufacturer
3.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Revenue by Manufacturer (2018-2023)
3.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Freeze-dried Human Rabies Vaccine (Vero Cells) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Freeze-dried Human Rabies Vaccine (Vero Cells) Manufacturer Market Share in 2022
3.4.2 Top 6 Freeze-dried Human Rabies Vaccine (Vero Cells) Manufacturer Market Share in 2022
3.5 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Overall Company Footprint Analysis
3.5.1 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Region Footprint
3.5.2 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Company Product Type Footprint
3.5.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Region
4.1.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2029)
4.1.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2029)
4.1.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Region (2018-2029)
4.2 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.3 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.4 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.5 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.6 Middle East and Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
5.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type (2018-2029)
5.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
6.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application (2018-2029)
6.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Application (2018-2029)
7 North America
7.1 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
7.2 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
7.3 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
7.3.1 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
7.3.2 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
8.2 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
8.3 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
8.3.1 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
8.3.2 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Region
9.3.1 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
10.2 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
10.3 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
10.3.1 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
10.3.2 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
11.3.1 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Freeze-dried Human Rabies Vaccine (Vero Cells) Market Drivers
12.2 Freeze-dried Human Rabies Vaccine (Vero Cells) Market Restraints
12.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Freeze-dried Human Rabies Vaccine (Vero Cells) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Freeze-dried Human Rabies Vaccine (Vero Cells)
13.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Production Process
13.4 Freeze-dried Human Rabies Vaccine (Vero Cells) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Freeze-dried Human Rabies Vaccine (Vero Cells) Typical Distributors
14.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 6. Sanofi Pasteur Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. Serum Institute of India Pvt. Basic Information, Manufacturing Base and Competitors
Table 9. Serum Institute of India Pvt. Major Business
Table 10. Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 11. Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Serum Institute of India Pvt. Recent Developments/Updates
Table 13. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 14. Bavarian Nordic Major Business
Table 15. Bavarian Nordic Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 16. Bavarian Nordic Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bavarian Nordic Recent Developments/Updates
Table 18. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Bharat Biotech Major Business
Table 20. Bharat Biotech Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 21. Bharat Biotech Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bharat Biotech Recent Developments/Updates
Table 23. AIM Vaccine Basic Information, Manufacturing Base and Competitors
Table 24. AIM Vaccine Major Business
Table 25. AIM Vaccine Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 26. AIM Vaccine Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AIM Vaccine Recent Developments/Updates
Table 28. Liaoning Yisheng Biopharma Basic Information, Manufacturing Base and Competitors
Table 29. Liaoning Yisheng Biopharma Major Business
Table 30. Liaoning Yisheng Biopharma Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 31. Liaoning Yisheng Biopharma Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Liaoning Yisheng Biopharma Recent Developments/Updates
Table 33. Changchun Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Zhuoyi Biological Major Business
Table 35. Changchun Zhuoyi Biological Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 36. Changchun Zhuoyi Biological Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Zhuoyi Biological Recent Developments/Updates
Table 38. Changchun Lnstitute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 39. Changchun Lnstitute of Biological Products Major Business
Table 40. Changchun Lnstitute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 41. Changchun Lnstitute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Changchun Lnstitute of Biological Products Recent Developments/Updates
Table 43. Liaoning Chengda Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Liaoning Chengda Biotechnology Major Business
Table 45. Liaoning Chengda Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 46. Liaoning Chengda Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Liaoning Chengda Biotechnology Recent Developments/Updates
Table 48. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Institute of Biological Products Major Business
Table 50. Wuhan Institute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 51. Wuhan Institute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Institute of Biological Products Recent Developments/Updates
Table 53. ShanDong Yidu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. ShanDong Yidu Biotechnology Major Business
Table 55. ShanDong Yidu Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 56. ShanDong Yidu Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. ShanDong Yidu Biotechnology Recent Developments/Updates
Table 58. Hualan Biological Bacterin Basic Information, Manufacturing Base and Competitors
Table 59. Hualan Biological Bacterin Major Business
Table 60. Hualan Biological Bacterin Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 61. Hualan Biological Bacterin Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hualan Biological Bacterin Recent Developments/Updates
Table 63. Guangzhou Promise Biologics Basic Information, Manufacturing Base and Competitors
Table 64. Guangzhou Promise Biologics Major Business
Table 65. Guangzhou Promise Biologics Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
Table 66. Guangzhou Promise Biologics Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Guangzhou Promise Biologics Recent Developments/Updates
Table 68. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Freeze-dried Human Rabies Vaccine (Vero Cells), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Freeze-dried Human Rabies Vaccine (Vero Cells) Production Site of Key Manufacturer
Table 73. Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Company Product Type Footprint
Table 74. Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Company Product Application Footprint
Table 75. Freeze-dried Human Rabies Vaccine (Vero Cells) New Market Entrants and Barriers to Market Entry
Table 76. Freeze-dried Human Rabies Vaccine (Vero Cells) Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Freeze-dried Human Rabies Vaccine (Vero Cells) Raw Material
Table 136. Key Manufacturers of Freeze-dried Human Rabies Vaccine (Vero Cells) Raw Materials
Table 137. Freeze-dried Human Rabies Vaccine (Vero Cells) Typical Distributors
Table 138. Freeze-dried Human Rabies Vaccine (Vero Cells) Typical Customers
List of Figures
Figure 1. Freeze-dried Human Rabies Vaccine (Vero Cells) Picture
Figure 2. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Type in 2022
Figure 4. Single Box Examples
Figure 5. Middle Box Examples
Figure 6. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Freeze-dried Human Rabies Vaccine (Vero Cells) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Freeze-dried Human Rabies Vaccine (Vero Cells) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Freeze-dried Human Rabies Vaccine (Vero Cells) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Freeze-dried Human Rabies Vaccine (Vero Cells) Market Drivers
Figure 73. Freeze-dried Human Rabies Vaccine (Vero Cells) Market Restraints
Figure 74. Freeze-dried Human Rabies Vaccine (Vero Cells) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Freeze-dried Human Rabies Vaccine (Vero Cells) in 2022
Figure 77. Manufacturing Process Analysis of Freeze-dried Human Rabies Vaccine (Vero Cells)
Figure 78. Freeze-dried Human Rabies Vaccine (Vero Cells) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の凍結乾燥ヒト狂犬病ワクチン(Vero細胞)市場2023年:企業・地域・タイプ・用途別分析(Global Freeze-dried Human Rabies Vaccine (Vero Cells) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆